GSK chief executive Andrew Witty told investors yesterday that Advair/Seretide sales are likely to continue to decline, although he insisted that the company is starting to see "some recovery in ...
Before taking over the top job from Sir Andrew Witty last April, Walmsley was head of GSK’s consumer business. But despite this background, Walmsley said that the company’s pharmaceuticals ...
(Reuters) -UnitedHealth CEO Andrew Witty said on Thursday that healthcare ... who was previously CEO of British drugmaker GlaxoSmithKline. UnitedHealth, which operates the biggest health insurer ...
UnitedHealth UNH.N CEO Andrew Witty said on Thursday that healthcare ... who was previously CEO of British drugmaker GlaxoSmithKline GSK.L. Drug costs:FTC report shows $7.3 billion in drug ...
(Reuters) -UnitedHealth CEO Andrew Witty said on Thursday that healthcare ... who was previously CEO of British drugmaker GlaxoSmithKline (NYSE:GSK). UnitedHealth (NYSE:UNH), which operates ...
(Reuters) -UnitedHealth CEO Andrew Witty said on Thursday that healthcare in the ... who was previously CEO of British drugmaker GlaxoSmithKline. UnitedHealth, which operates the biggest health ...
executive Andrew Witty Thursday said the U.S. healthcare ... who ran the big drugmaker GlaxoSmithKline for nearly a decade before joining UnitedHealth Group’s management team to run Optum ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback